Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients.

Ragab D, Laird M, Duffy D, Casrouge A, Mamdouh R, Abass A, Shenawy DE, Shebl AM, Elkashef WF, Zalata KR, Kamal M, Esmat G, Bonnard P, Fontanet A, Rafik M, Albert ML.

Cytokine. 2013 Aug;63(2):105-12. doi: 10.1016/j.cyto.2013.04.016. Epub 2013 May 7. Erratum in: Cytokine. 2014 Jan;65(1):119-20.

PMID:
23664274
2.

Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A, Mallet V, Mottez E, Mapes J, Fontanet A, Pol S, Albert ML.

J Clin Invest. 2011 Jan;121(1):308-17. doi: 10.1172/JCI40594. Epub 2010 Dec 22.

3.

Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection.

Riva A, Laird M, Casrouge A, Ambrozaitis A, Williams R, Naoumov NV, Albert ML, Chokshi S.

Hepatology. 2014 Aug;60(2):487-96. doi: 10.1002/hep.27139. Epub 2014 May 19.

PMID:
24668726
4.

The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.

Larrubia JR, Calvino M, Benito S, Sanz-de-Villalobos E, Perna C, Pérez-Hornedo J, González-Mateos F, García-Garzón S, Bienvenido A, Parra T.

J Hepatol. 2007 Nov;47(5):632-41. Epub 2007 May 24.

PMID:
17560677
5.

Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection.

Söderholm J, Waldenström J, Askarieh G, Pilli M, Bochud PY, Negro F, Pawlotsky JM, Zeuzem S, Ferrari C, Norkrans G, Wejstål R, Westin J, Neumann AU, Haagmans BL, Lindh M, Missale G, Hellstrand K, Lagging M.

PLoS One. 2013;8(2):e56991. doi: 10.1371/journal.pone.0056991. Epub 2013 Feb 20.

6.

Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.

Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M, Jacobson IM, Dimova R, Markatou M, Talal AH.

Hepatology. 2008 Nov;48(5):1440-50. doi: 10.1002/hep.22500.

7.

Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.

Zeremski M, Dimova R, Brown Q, Jacobson IM, Markatou M, Talal AH.

J Infect Dis. 2009 Dec 1;200(11):1774-80. doi: 10.1086/646614.

PMID:
19848607
8.

Chemokine antagonism in chronic hepatitis C virus infection.

Charles ED, Dustin LB.

J Clin Invest. 2011 Jan;121(1):25-7. doi: 10.1172/JCI45610. Epub 2010 Dec 22.

9.

Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection.

Yonekura K, Ichida T, Sato K, Yamagiwa S, Uchida M, Sugahara S, Ito S, Abo T, Asakura H.

Liver. 2000 Oct;20(5):357-65.

PMID:
11092253
10.

Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.

Harvey CE, Post JJ, Palladinetti P, Freeman AJ, Ffrench RA, Kumar RK, Marinos G, Lloyd AR.

J Leukoc Biol. 2003 Sep;74(3):360-9.

PMID:
12949239
11.

Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.

Tacke F, Zimmermann HW, Berres ML, Trautwein C, Wasmuth HE.

Liver Int. 2011 Jul;31(6):840-9. doi: 10.1111/j.1478-3231.2011.02504.x. Epub 2011 Mar 10.

PMID:
21645215
12.

Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.

Helbig KJ, Ruszkiewicz A, Lanford RE, Berzsenyi MD, Harley HA, McColl SR, Beard MR.

J Virol. 2009 Jan;83(2):836-46. doi: 10.1128/JVI.01388-08. Epub 2008 Nov 5.

13.

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.

Zeremski M, Petrovic LM, Talal AH.

J Viral Hepat. 2007 Oct;14(10):675-87. Review.

PMID:
17875002
14.

CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis.

Antonelli A, Ferri C, Fallahi P, Ferrari SM, Frascerra S, Pampana A, Panicucci E, Carpi A, Nicolini A, Ferrannini E.

J Interferon Cytokine Res. 2009 Jun;29(6):345-51. doi: 10.1089/jir.2008.0090.

PMID:
19441886
15.

Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: its relationship to liver inflammation.

Wang J, Holmes TH, Cheung R, Greenberg HB, He XS.

J Infect Dis. 2004 Sep 1;190(5):989-97. Epub 2004 Jul 23.

PMID:
15295707
16.

CXCR3 Expression Elevated on Peripheral CD8(+) Lymphocytes from HIV/HCV Coinfected Individuals.

Kimball P, McDougan F, Stirling R.

Viral Immunol. 2011 Dec;24(6):441-8. doi: 10.1089/vim.2011.0035. Epub 2011 Nov 23.

PMID:
22111598
17.

Thyroid disturbance related to chronic hepatitis C infection: role of CXCL10.

Danilovic DL, Mendes-Correa MC, Chammas MC, Zambrini H, Barros RK, Marui S.

Endocr J. 2013;60(5):583-90. Epub 2013 Jan 5.

18.

High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.

Antonelli A, Ferri C, Fallahi P, Ferrari SM, Sebastiani M, Ferrari D, Giunti M, Frascerra S, Tolari S, Franzoni F, Galetta F, Marchi S, Ferrannini E.

Am J Gastroenterol. 2008 Oct;103(10):2488-94. doi: 10.1111/j.1572-0241.2008.02040.x. Epub 2008 Sep 4.

PMID:
18775023
19.

CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.

D'Agosto G, Trento E, Nosotti L, Bordignon V, Battista M, Prignano G, Pimpinelli F, Biolcati G, Macrì A, Palamara G, Miglioresi L, Morrone A, Di Carlo A, Cordiali-Fei P, Ensoli F.

J Biol Regul Homeost Agents. 2009 Jul-Sep;23(3):155-64.

PMID:
19828092
20.

Supplemental Content

Support Center